Vaccine candidates are being offered through an Emergency Use Authorization by the Food and Drug Administration. Getting the vaccine protects yourself, your family, your community and our nation.
The Department of Defense is implementing a standardized and coordinated strategy for prioritizing, distributing, and administering a COVID-19 vaccine(s) through a phased approach to DoD uniformed service members, both the active and Selected Reserve components, including members of the National Guard; dependents; retirees; civilian employees, and selected DoD contract personnel as authorized in accordance with DoD regulation.
The Department’s priorities are:
- Protecting our Service members, DoD civilians, and families
- Safeguarding our national security capabilities
- Supporting the whole-of-nation response to the COVID-19 pandemic
COVID-19 Vaccine Toolkit PageTRICARE Beneficiary Information
About the COVID-19 Vaccine
COVID-19 vaccines are being developed as quickly as possible and we understand there may be concerns, but processes and procedures are in place to ensure the safety of any vaccine that is authorized for use. Vaccine(s) for COVID-19 are only available after they are:
- Demonstrated to be safe and effective in large phase three clinical trials
- Authorized by the U.S. Food and Drug Administration
- Manufactured and distributed safely and securely
Visit the Centers for Disease Control and Prevention to learn more about the COVID-19 vaccine.
You also may be interested in...
Policy
This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.
Policy
This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.
Video
12/28/2020
See how MHS is leading a phased approach to offer 11.1 million Department of Defense personnel the first COVID-19 vaccines. To learn more about the safety and efficacy behind COVID-19 vaccines, go to: https://www.health.mil/Military-Health-Topics/Combat-Support/Public-Health/Coronavirus/COVID-19-Vaccine-Efforts.
Recommended Content:
COVID-19 Vaccine Efforts | Coronavirus | COVID-19 Vaccine Toolkit
Policy
This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.
Showing results 1 - 15
Page 1 of 3